Literature DB >> 2494619

Maternal age and screening for gestational diabetes: a population-based study.

D R Coustan1, C Nelson, M W Carpenter, S R Carr, L Rotondo, J A Widness.   

Abstract

The American College of Obstetricians and Gynecologists (ACOG) has recommended screening for gestational diabetes, using a 50-g, 1-hour glucose challenge (threshold for further testing 140 mg/dL or higher), for all pregnant women aged 30 or older and for younger women with risk factors. In order to assess these recommendations, we collected demographic and historic data on 6214 pregnant women representing a population of universally screened individuals. Of 125 cases of gestational diabetes diagnosed (ACOG criteria), 70 patients (56%) were under the age of 30. In addition, 44% of gestational diabetics had no risk factors. The cost per case diagnosed would be $190 with the ACOG recommendations, $192 if the age for routine screening were lowered to 25 years or more, and $222 if universal screening were practiced. Using the ACOG recommendations, 35% of gestational diabetes would go undiagnosed, with little cost savings.

Entities:  

Mesh:

Year:  1989        PMID: 2494619

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  25 in total

Review 1.  Screening for diabetes in pregnancy.

Authors:  S Virjee; S Robinson; D G Johnston
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

2.  Maternal diabetes and hypertensive disorders in association with autism spectrum disorder.

Authors:  Christina Cordero; Gayle C Windham; Laura A Schieve; Margaret Daniele Fallin; Lisa A Croen; Anna Maria Siega-Riz; Stephanie M Engel; Amy H Herring; Alison M Stuebe; Catherine J Vladutiu; Julie L Daniels
Journal:  Autism Res       Date:  2019-04-10       Impact factor: 5.216

Review 3.  Periodic health examination, 1992 update: 1. Screening for gestational diabetes mellitus. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

4.  Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Zhong Dong; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

Review 5.  Gestational diabetes screening after HAPO: has anything changed?

Authors:  Wadia R Mulla; Tasmia Q Henry; Carol J Homko
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

Review 6.  Gestational diabetes mellitus: an updated overview.

Authors:  E Chiefari; B Arcidiacono; D Foti; A Brunetti
Journal:  J Endocrinol Invest       Date:  2017-03-10       Impact factor: 4.256

7.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

Review 8.  Exercise guidelines for gestational diabetes mellitus.

Authors:  Cliantha Padayachee; Jeff S Coombes
Journal:  World J Diabetes       Date:  2015-07-25

9.  Bridging Gaps and Understanding Disparities in Gestational Diabetes Mellitus to Improve Perinatal Outcomes.

Authors:  Sean S Daneshmand; Sharon Stortz; Robin Morrisey; Arij Faksh
Journal:  Diabetes Spectr       Date:  2019-11

10.  Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.

Authors:  Rahul Pannala; Jeffery B Leirness; William R Bamlet; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.